Enzyme improves sweetener and beverage alcohol production.
Share:
Press Release Summary:
Designed to promote process efficiency, Veretase(TM) alpha-amylase breaks down starch into more uniform blend of lower molecular weight oligosaccharides to improve saccharification and fermentation efficiency and consistency. Effective over wide temperature and pH range, enzyme is used for liquefaction of starch-based mashes and slurries in food and beverage applications. It promotes operational flexibility by allowing greater mash viscosity reduction at lower dosage levels.
Original Press Release:
Verenium Launches High Performance Enzyme for Food and Beverage Applications
- Veretase(TM) alpha-amylase significantly improves efficiency and economics of sweetener and beverage alcohol production -
CAMBRIDGE, Mass., April 13 -- Verenium Corporation (NASDAQ:VRNM), a pioneer in the development of high-performance specialty enzymes and next-generation cellulosic ethanol, today announced the introduction of Veretase, a unique enzyme for the liquefaction of starch-based mashes and slurries specifically for use in food and beverage applications. This high performance enzyme improves saccharification and fermentation efficiency and consistency. Effective over a wide temperature and pH range, Veretase allows sweetener and beverage alcohol producers greater operational flexibility providing mash viscosity reduction at a much lower dose over competitive products.
"Verenium is pleased to introduce this unique enzyme specifically designed to improve the economics and efficiency in the sweetener and beverage alcohol production market," said Janet Roemer, Verenium's Executive Vice President, Specialty Enzymes Business. "Veretase will offer customers greater operational flexibility in the plant reducing processing costs considerably."
Verenium estimates the addressable global market for Veretase for sweeteners and beverage alcohol production to be in excess of $80 million annually.
Verenium began marketing and selling Veretase directly to sweetener and beverage alcohol producers in the first quarter of 2009 and manufactures the enzyme under its agreement with Fermic S.A. de C.V.
About Veretase alpha-amylase
Veretase alpha-amylase is a high performance enzyme designed to significantly improve the efficiency and economics of sweetener and beverage alcohol production. With a unique mode of action this enzyme breaks down starch into a more uniform blend of lower molecular weight oligosaccharides, improving saccharification and fermentation efficiency and consistency. Veretase has been shown to be effective over an exceptionally wide temperature and pH range providing sweetener and beverage alcohol producers greater operational flexibility and reduced processing costs. Veretase also provides exceptional mash viscosity reduction at a much lower dose over competitive products.
About Verenium
Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and animal health markets. The Company possesses integrated, end-to-end capabilities and cutting-edge technology in pre-treatment, novel enzyme development, fermentation and project development for next-generation biofuels. Through a joint venture with BP, the Company is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of non-food feedstocks, including dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.
Verenium's Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes-proteins that act as the catalysts of biochemical reactions. For more information on Verenium, visit http://www.verenium.com/.
Verenium Contacts:
Kelly Lindenboom
Vice President, Corporate Communications
617-674-5335
kelly.lindenboom@verenium.com
Sarah Carmody
Sr. Corporate Communications Associate
617-674-5357
sarah.carmody@verenium.com
